NASDAQ:PBLA

Panbela Therapeutics Stock Signals

etoro logo Buy PBLA
*Your capital is at risk
$0.0050
-0.0061 (-54.95%)
At Close: Jun 22, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Panbela Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 81 days ( 33.77 %
Last Price $0.0050 -54.95 %
Performance History
7 Days
$0.0111 $0.0050
-54.95%
30 Days
$0.0010 $0.0050
400.00%
12 Mos
$0.200 $0.0050
-97.50%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 40.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0050 - $0.0050
Trend - 3 mos 53.17 % High Width: 697.67 %
Pred. range - 3 mos $0.0033 - $0.0263 Low -33.99 % - 426.53 %
Volume Direction Sell High Volume: 281 · Direction: 0
Pivot Short Sell Very Low Apr 20, 2026 - 44 days
RSI Short Pivot Signal Buy Very Low May 07, 2026 - 31 days
Short MA 3 mos Sell Low Apr 27, 2026 - 39 days
Long MA 3 mos Sell Medium Jun 18, 2026 - 2 days
Short/Long MA 3 mos Buy Medium Jun 08, 2026 - 10 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 25.98
Signal Type Signal Value Importance Data
Trend - 12 mos -94.45 % Very High Width: 108.98 %
Pred. range - 12 mos N/A - $0.0006 High -100.00 % - -88.47 %
Short MA 12 mos Sell Very High Jun 18, 2026 - 2 days
Long MA 12 mos Sell Very High Jun 18, 2026 - 2 days
Short/Long MA 12 mos Sell Very High May 18, 2026 - 24 days
Pivot Long Sell Low Jun 18, 2026 - 2 days
RSI Long Pivot Signal Buy Low May 18, 2026 - 24 days
Bollinger Buy Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT PANBELA THERAPEUTICS INC.
Panbela Therapeutics
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE